Bausch Lomb Greece

Bausch + Lomb is a modern multinational pharmaceutical company that manufactures and markets a broad range of branded OTC products, food supplements and medical devices. Founded in 1853, the company has a significant global presence in Research and Development, manufacturing and commercial operations, with more than employees and activities in over 100 countries worldwide. Bausch + Lomb offers a diverse product portfolio focused on Eye Health and General Health, helping people See Better and Live Better. In Greece, some of its most well-known products include Artelac®, Ocuvite®, Lumify® Biotrue®, ReNu®, Niflamol®, Counterpain®, Ezixin®, Vidilac®, Yellox® and Dexamytrex®. Our mission is simple: We help people see better to live better, all over the world. For nearly two centuries, we have evolved alongside the changing needs of our patients and customers. Our commitment to innovation and to continuously advancing eye care has never been stronger. From contact lenses and prescription or OTC products to surgical devices and more, we turn innovative ideas into better outcomes, driven by passion, perseverance and purpose. In 2018, Bausch + Lomb Greece became the first pharmaceutical company in Europe to be certified under ISO 37001 for Anti-Bribery Management Systems. Moreover, since 2019, the company has been consistently recognized among the top-ranked employers in the Best Workplaces™ Hellas awards, in the category of companies with 50–250 employees. In 2025, Bausch + Lomb Greece is listed among the "100 Best Companies to Work For in Europe 2025", according to the "Fortune's 100 Best Companies to Work For in Europe 2025" list of Great Place to Work® Europe.